Medical Device | December 30, 2021
Siemens Healthineers receive EUA for Covid-19 antigen self-test
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of Covid-19 exposure
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of Covid-19 exposure
It plans to deliver over 300 million doses to the Indian government
The company will market it under the brand name Molflu
The Covid-19 At-Home Test uses a simple nasal swab sample to enable individuals to self-test at home and receive accurate, reliable and quick results in as few as 20 minutes for SARS-CoV-2 and all known variants of concern, including Omicron
SK bioscience secures long-term license to supply the Novavax vaccine for the Korean market
The company has started manufacturing the Sputnik Light vaccine
The Indian Council of Medical Research (ICMR), intends to enter into non-exclusive agreements with companies
The company will manufacture a cancer immunotherapy product from 2022
The total cost of the project is estimated at Rs 30 crore
The interim results of Phase 3 clinical trials conducted by CanSinoBIO demonstrated that Convidecia has an efficacy of 95.47% at preventing severe disease 14 days after single-dose vaccination.
Subscribe To Our Newsletter & Stay Updated
